Text and Data Mining valid from 2019-04-30
Received: 22 January 2019
Accepted: 3 April 2019
First Online: 30 April 2019
Ethics approval and consent to participate
: This study was conducted in accordance with the Declaration of Helsinki and applicable laws and regulations and has been approved by the local institutional review board at the University Hospital of Tübingen, Germany (Project No. 364/2014BO2). All participants provided written informed consent before study inclusion.
: Not applicable.
: M.W. Löffler, D.J. Kowalewski, H. Schuster, S. Stevanović, and S.P. Haen are the inventors of patents owned by Immatics Biotechnologies GmbH. D.J. Kowalewski and H. Schuster are currently employees of Immatics Biotechnologies GmbH. H.G. Rammensee has ownership interest (including patents) in Immatics Biotechnologies GmbH, CureVac AG, and Synimmune GmbH. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.